DUALITY ADVISERS, LP - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 222 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
DUALITY ADVISERS, LP ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$710,771
+79.3%
73,808
+98.1%
0.09%
+72.0%
Q2 2023$396,489
+11.5%
37,264
+10.2%
0.05%
+25.0%
Q1 2023$355,692
-61.7%
33,811
-54.9%
0.04%
-62.3%
Q4 2022$929,362
-49.1%
75,009
-57.4%
0.11%
-46.7%
Q3 2022$1,826,000
+194.5%
176,248
+227.9%
0.20%
+226.2%
Q2 2022$620,000
+210.0%
53,744
+237.8%
0.06%
+190.5%
Q1 2022$200,000
-87.7%
15,910
-88.8%
0.02%
-82.6%
Q4 2020$1,621,000
+48.9%
142,346
+17.6%
0.12%
+72.9%
Q3 2020$1,089,000121,0700.07%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Sarissa Capital Management LP 16,390,000$172,422,80022.05%
13D Management LLC 533,562$5,613,0732.85%
Quantedge Capital Pte Ltd 541,200$5,693,4242.22%
Price Jennifer C. 520,000$5,470,4001.74%
Tamarack Advisers, LP 210,000$2,209,2000.81%
Intrinsic Value Partners, LLC 51,605$542,8850.73%
Brown Capital Management 3,933,933$41,384,9750.62%
Old West Investment Management, LLC 75,219$791,3030.43%
EMC Capital Management 43,315$4560.38%
Hillsdale Investment Management Inc. 420,617$4,424,8910.38%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders